表紙
市場調查報告書

幹細胞再程序化實現的技術進步

Technological Advances Enabling Stem Cells Reprogramming

出版商 Frost & Sullivan 商品編碼 841546
出版日期 內容資訊 英文 75 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
幹細胞再程序化實現的技術進步 Technological Advances Enabling Stem Cells Reprogramming
出版日期: 2019年04月30日內容資訊: 英文 75 Pages
簡介

本報告提供全球幹細胞再程序化市場相關調查,技術概要、檢討、評估,商務環境與專利趨勢,資金、投資環境,技術發展藍圖和關注的技術平台,及市場預測等彙整資料。

第1章 摘要整理

第2章 技術概要、趨勢

  • 分析的主要素:幹細胞再程序化
  • 幹細胞再程序化的概要
  • 進化的幹細胞再程序化
  • 多功能誘導的傳達法
  • 多功能誘導的分子法

第3章 技術情形的檢討、評估

  • 幹細胞再程序化的革新
  • 幹細胞再程序化的開發
  • 幹細胞再程序化的進步
  • 幹細胞再程序化的技術
  • 幹細胞再程序化的突破
  • 幹細胞再程序化的破壞
  • 幹細胞再程序化的方法
  • 幹細胞再程序化的平台
  • 幹細胞再程序化的新穎性
  • 幹細胞再程序化的革新

第4章 複數產業的影響

  • 市場動態、商務機會
  • 市場預測:各應用領域
  • 市場預測:各來源
  • 市場預測:各部門
  • 市場預測:各技術
  • 市場預測:各地區

第5章 商務環境、智慧財產權分析

  • 技術的協同效應再形成價值鏈
  • 促進解決方案的新的方法
  • 經營模式的雜合反應
  • 技術、商務環境:促進因素
  • 技術、商務環境:課題
  • 技術轉移的評估、認識
  • 最重要的創新者、專利所有者

第6章 資金、投資環境

  • 資金、投資模式、引進
  • 對資金趨勢、捐款的關注
  • 主要的資金來源
  • 資金援助計劃:各地區
  • 資金最多的機關

第7章 技術路徑規劃、效能基準

  • 活用技術協同效應的藍圖
  • 基準的多標準方法
  • 策略組合評估
  • 第1級標準:革新的發展
  • 第1級標準:財務成果
  • 第1級標準:市場演進
  • 第2級標準:為了成功的主要行動
  • 分析效能結果
  • 多標準的最後評估
  • 幹細胞再程序化的未來展望

第8章 促進幹細胞再程序化的技術平台

  • 值得注意的技術平台
  • 策略性的商務案例
  • 策略性的商務開發
  • 重要的成功要素

第9章 主要產業影響者

目錄
Product Code: D89C

Technologies Paving New Avenues to Drive Breakthrough Research Toward the Discovery of Next Generation Therapeutics

Since the advent of stem cells reprogramming after the discovery of the differentiation factors that allow the creation of human induced pluripotent stem cells, researchers all around the world are strongly committed to develop novel methods to design and build human stem cells.

Indeed, there is an increasing demand for the more efficient production systems and manufacturing methods of stem cells for potential investigation in disease management. This trend is emphatically envisaged to accelerate the development of both regenerative medicine and drug discovery and development.

Moreover, stem cell therapies are acclaimed as the next major advancements in transforming healthcare. Pharmaceutical companies are heavily investing in expanding their cellular therapy portfolio based on stem cells reprogramming, thereby exhibiting a strong evidence of the understanding future of stem cells reprogramming in the treatment of a broad spectrum of life-threatening diseases.

Table of Contents

1.0 EXECUTIVE SUMMARY

  • 1.1. Stem Cells Reprogramming: The Bigger Picture
  • 1.2. Stem Cells Reprogramming: A Promising Revolution
  • 1.3. Research Focus: Stem Cells Reprogramming
  • 1.4. Research Focus: Stem Cells Reprogramming
  • 1.5. Research Scope: Unveiling a Radically Novel Technology
  • 1.6. Analysis Framework: Frost & Sullivan's Core Value
  • 1.7. Research Methodology: Five Steps toward Success

2.0 TECHNOLOGY SNAPSHOT AND TRENDS

  • 2.1. Key Elements of Analysis: Stem Cells Reprogramming
  • 2.2. Brief Overview of Stem Cells Reprogramming
  • 2.3. Evolving Stem Cells Reprogramming
  • 2.4. Delivery Methods of Pluripotency Induction
  • 2.5. Molecular Methods of Pluripotency Induction

3.0 TECHNOLOGY STATUS REVIEW AND ASSESSMENT

  • 3.1. Stem Cells Reprogramming Innovations
  • 3.2. Stem Cells Reprogramming Developments
  • 3.3. Stem Cells Reprogramming Advances
  • 3.4. Stem Cells Reprogramming Technologies
  • 3.5. Stem Cells Reprogramming Breakthroughs
  • 3.6. Stem Cells Reprogramming Disruption
  • 3.7. Stem Cells Reprogramming Approaches
  • 3.8. Stem Cells Reprogramming Platforms
  • 3.9. Stem Cells Reprogramming Novelties
  • 3.10. Stem Cells Reprogramming Innovations

4.0 IMPACT ACROSS MULTIPLE INDUSTRIES

  • 4.1. Market Dynamics and Business Opportunities
  • 4.2. Market Forecast by Application
  • 4.3. Market Forecast by Source
  • 4.4. Market Forecast by Sector
  • 4.5. Market Forecast by Technology
  • 4.6. Market Forecast by Region

5.0 BUSINESS LANDSCAPE AND INTELLECTUAL PROPERTY ANALYSIS

  • 5.1. Technology Synergy Reshaping the Value Chain
  • 5.2. New Approaches Driving Solutions
  • 5.3. Business Model Hybridization
  • 5.4. Technology and Business Landscape: Accelerators
  • 5.5. Technology and Business Landscape: Challenges
  • 5.6. Technology Transfer Assessment and Perceptions
  • 5.7. Principal Innovators and Patent Holders

6.0 FUNDING AND INVESTMENT LANDSCAPE

  • 6.1. Funding and Investment Models and Adoption
  • 6.2. Funding Trends and Contribution Focus
  • 6.3. Principal Funding Sources
  • 6.4. Funded Programs by Region
  • 6.5. Most Granted Institutions

7.0 TECHNOLOGY ROADMAPPING AND PERFORMANCE BENCHMARKING

  • 7.1. Roadmap Tapping into Technology Synergy
  • 7.2. Multicriteria Approach for Benchmarking
  • 7.3. Strategic Portfolio Assessment
  • 7.4. Level 1 Criteria: Innovation Development
  • 7.5. Level 1 Criteria: Financial Performance
  • 7.6. Level 1 Criteria: Market Evolution
  • 7.7. Level 2 Criteria: Key Actions for Success
  • 7.8. Analytic Performance Results
  • 7.9. Multicriteria Final Assessment
  • 7.10. Future Perspective for Stem Cells Reprogramming

8.0 TECHNOLOGY PLATFORMS ADVANCING STEM CELLS REPROGRAMMING

  • 8.1. Technology Platforms to Watch
  • 8.2. Strategic Business Cases
  • 8.3. Strategic Business Developments
  • 8.4. Critical Success Factors

9.0 KEY INDUSTRY INFLUENCERS

  • 9.1. Key Industry Influencers
  • 9.2. Key Industry Models
  • 9.3. Key Industry Participants
  • 9.4. Key Industry References
  • 9.5. Key Industry Exemplars
  • Legal Disclaimer
Back to Top